Colorectal cancer: diagnosis and treatment
HEQ examines risk factors and screening protocols for the world’s third most common form of cancer - colorectal cancer.
With more than 1.8 million new...
The Wellbeing Business: exploring workplace mental health
The Wellbeing Business founder Zoe Eccleston speaks with HEQ about the importance of good mental health in the workplace.
Workplace health and wellbeing expert Zoe...
NHS Scotland £53m vital PPE deal to create 200 jobs
A £53m deal has been struck that will see vital PPE equipment manufactured for NHS Scotland – creating 200 new jobs.
The First Minister for...
UK government to record COVID-19 deaths with new methodology
Today, the publication of daily data on coronavirus deaths will resume using a new methodology to calculate the figures.
Following a review by Public Health...
Infection control guidance resource for home care providers
The UK Government has created a guidance resource on infection control measures for those providing home care.
The resource has been collated for care providers...
The Centers for Disease Control and Prevention and COVID-19
HEQ explores the CDC’s response to the COVID-19 pandemic.
With infection rates in many states still well above public safety standards set by the World...
CBD blockchain tracing: new levels of transparency and accountability
The Cannabinoid Association of the Netherlands has launched a free to use blockchain-based search tool.
In a bid to drive higher levels of transparency and...
Successful initial results using cannabis terpenes to treat COVID-19
A study to test the efficacy of a unique cannabis terpene formulation for the treatment of viral infections, including COVID-19, has shown early promising...
European Commission reaches agreement on potential COVID-19 vaccine
Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19.
Once the vaccine has...
First at-home treatment for spinal muscular atrophy approved by FDA
The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA).
The treatment – Evrysdi...
COVID-19 detection kits market to grow 17.3% through 2026
The COVID-19 detection kits market is estimated to reach $8.5bn (€7.19bn) by the year 2026.
According to a study conducted by Global Market Insights, Inc.,...
Laboratory automation: exploring the benefits and challenges
In this article, Todd Graham, a freelance scientist at Kolabtree, discusses the benefits and challenges of laboratory automation.
Automation has transformed laboratories over the past...
Latest Publication
Health Europa Quarterly Issue 13
Welcome to Health Europa Quarterly Issue 13, which focuses – inevitably – on issues surrounding the Covid-19 pandemic, from the importance of hand hygiene...
Media Partners
EVENT PARTNERS
LATEST HEALTH EBOOKS
Understanding MPS and other similar Lysosomal diseases
MPS Austria wants to make everyday life easier for children with Mucopolysaccharidosis and other similar Lysosomal diseases, and their families, by supporting them with...
Introducing the Narrenturm: the world’s first hospital for the mentally ill
Before the end of the 18th century, those who were mentally ill were not regarded as patients, however in 1784 Austria, the Narrenturm was...
The BRoTHER project: promoting digitalisation in biobanking research
Improving personalised medicine by increasing digitalisation throughout the field of biobanking research, we present to you our partner brochure with: BRoTHER
Biobanking is used in...
Living with mucopolysaccharidoses: support, awareness and research
Mucopolysaccharidoses (MPS) is a group of rare, inherited, incurable metabolic diseases caused by disorders in the metabolism, in this eBook the Austrian MPS Society...
LATEST PARTNERS
Easy, Low Cost, Legal Digital Transactions
California-based Artery Inc. provides easy, low cost banking alternatives and digital transaction services on blockchain to help business owners in cash heavy industries safely...
MPS Austria: champions of self-help support and research for therapy
Mucopolysaccharidoses (MPS) are slowly progressive and inheritable metabolic diseases and MPS Austria helps to improve quality of life for MPS patients.
MPS diseases occur in...
Pharmacovigilance and life sciences services, brought to you by ProPharma Group
While covering six continents with their pharmacovigilance services, ProPharma Group are exceptionally committed to the safety of patients.
ProPharma Group is an industry leader providing...
PillTime: the digital pharmacy using robotic technology
Discover the world of PillTime, the digital pharmacy that uses robotic technology to improve medication management in community and healthcare settings.
When organising a lot...
MEDICAL CANNABIS NETWORK
Project Twenty21: Europe’s largest medical cannabis registry goes live
Drug Science’s Project Twenty21, Europe’s largest medical cannabis patient registry, has gone live today, registering its first patient for a medical cannabis prescription.
The Project...
Currency UK: assessing the impact of COVID-19 on the CBD sector
Currency UK Head of Sales Ben Kohler assesses the impact of COVID-19 on foreign exchange within the CBD sector.
With CBD still being a relatively...
Advocacy group launches Australian Medicinal Cannabis Course Online
The recent Senate recommendations to substantially increase medical cannabis education for health professionals are being implemented by a leading advocacy group with the launch...
Introducing PLEA: the patient run medical cannabis advocacy group
Founded by a team of patient advocates with experience in the medical cannabis sector, PLEA has been set up to accelerate the integration of...
Latest MCN Publication
Medical Cannabis Network Quarterly Issue 3
Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our third edition, which looks at cannabis research, policy, and national and international regulation of cannabis.
Welcome...
